Business news – Page 63
-
BusinessChemours sheds disinfectants and aniline
Dow Chemical and Germany’s Lanxess will buy plants as Chemours restructures following its spin-off from DuPont
-
OpinionHealing the world
Will GSK’s move towards licensing patents in developing countries, rather than rigidly defending them, improve access to medicines?
-
BusinessPumping up industrial wasted heat
Company profile: Qpinch reclaims wasted energy by mimicking nature
-
BusinessFDA moves to withdraw swine drug carbadox
Carcinogenic antibiotic has been banned in EU, Canada and Australia for years
-
BusinessSurge in US industry investment linked to shale gas
264 expansion or construction projects announced, of which 40% have commenced or completed
-
BusinessUS treasury rules scupper Pfizer–Allergan merger
Government aims to crack down on corporate tax avoidance through ‘inversion’ deals
-
BusinessDuPont shutters US plant where leak killed four workers
La Porte plant will not reopen after fatal methyl mercaptan leak in 2014
-
BusinessCalifornian hazard warning website criticised
Site providing information related to state’s Proposition 65 law is ‘inaccurate’ says industry association
-
NewsBP’s long legal battle over Deepwater disaster ends
Judge finalises BP’s $20 billion settlement over Gulf of Mexico oil spill
-
BusinessTwo dead in explosion at Chinese chemical plant
Five others injured when wastewater treatment device detonated
-
OpinionChecks and balances
Should trade bodies do more than simply ‘represent their members’ interests’?
-
OpinionThrowing things over the fence
Saying ‘That’s someone else’s problem’ is asking for trouble, says Derek Lowe
-
BusinessGilead loses to Merck & Co in hepatitis C drug dispute
US court upholds Merck’s claim to patents related to blockbuster drugs
-
BusinessMEGlobal to build $1bn US petrochemical plant
Ethylene glycol company announces plans for first US facility
-
BusinessIndian whistleblower pushes for regulatory reform
Although denied a hearing by India’s supreme court, Dinesh Thakur wants to shake up pharmaceutical safety laws
-
FeatureEnzymes for everyone
Can scientists overcome enzymes’ fragility and exploit their speed and specificity? Fiona Case investigates
-
BusinessRoche sketches out Blueprint collaboration
Drug discovery startup will contribute to cancer immunotherapy projects aimed at kinase enzymes
-
BusinessIndia bans 344 combination drugs
Manufacturers appeal to courts to allow continued sales of products the government deems risky
-
BusinessSanction lift triggers investment in Iran
Ambitious state plans and openness to foreign companies could combine to revive Iran’s chemical industry
-
OpinionDrugs don’t grow on trees
The trope of companies profiteering from academic discoveries doesn’t bear much scrutiny, says Derek Lowe